YOQNEAM, Israel and SAN RAMON, California, October 11 /PRNewswire/ -- Results of an independent multi-treatment clinical study of the UltraShape Contour I, the first clinically proven non-invasive focused ultrasound solution for body contouring, will be presented at the American Society for Dermatologic Surgery annual meeting on October 11, 2007 in Chicago, Illinois. The presentation is entitled "Non-invasive Ultrasonic Selective Destruction of Adipocytes using UltraShape" and will take place during the scientific session Total Body Rejuvenation.
Hector Leal-Silva, M.D., a dermatologic surgeon based in Monterrey, Mexico, will present the results of the 36 patient clinical study using the UltraShape system on localized fat deposits in the abdomen, flanks, and thighs. The study showed definitive, measurable results in 100 percent of patients including an average of two-inch (5cm) reduction in circumference in the abdomen after a series of three treatments, one month apart. Photographic assessment, weight and circumferential measures were evaluated before and after each treatment and one month after the last treatment. CT scans taken in a subset of study subjects showed objectively quantifiable fat thickness reduction. Ninety-four percent (94%) of patients were satisfied with the procedure. In addition, there were no adverse events reported.
"During my 18 month clinical experience, I continue to be impressed with the UltraShape procedure," said Leal. "My clinical study demonstrated measurable circumference reduction in all patients. These results were further supported by CT scans in a subset of patients showing a sustained reduction in fat thickness. In addition, the UltraShape procedure had high patient satisfaction confirming that it is meeting patient expectations and the high demand for safe and effective non-invasive fat reduction in today's aesthetic practice."
"Physicians and consumers are looking for an effective non-invasive fat reduction and body contouring treatment that yields long-lasting results and high patient satisfaction and have found this in UltraShape," said Rodger Stewart, President and Chief Executive Officer of UltraShape Inc.
About the UltraShape Contour I
The UltraShape Contour I system, based on patented focused ultrasound technology, is the first scientifically and clinically proven non-invasive body contouring solution for both men and women. The device produces mechanical, non-thermal, acoustic effects which targets and selectively destroys fat cells, leaving surrounding critical structures such as skin, blood vessels, nerves, and connective tissue intact. The UltraShape procedure is guided by proprietary real-time tracking and guidance technology designed to deliver smooth, uniform body contouring results. The software guarantees adherence to a pre-determined treatment algorithm minimizing risk of contour irregularities, a common side effect of liposuction. The UltraShape procedure is performed during a convenient, "walk-in, walk-out" session carried out in an office-based environment; it requires no anesthesia or sedation, and the vast majority of patients report no pain or discomfort. After treatment, patients immediately resume their daily routines with no need for maintenance treatments. The UltraShape procedure is available in 47 countries and over 40,000 patient treatments have been performed worldwide with high patient satisfaction. The UltraShape Contour I received the CE Mark in 2005 and a medical device license from Health Canada in 2007. The UltraShape Contour I system is not available for sale in the United States.
UltraShape is redefining aesthetic medicine by developing, manufacturing and marketing innovative non-invasive technologies for body contouring. The company is dedicated to providing clinically proven safe and effective solutions that enhance the lives of patients worldwide. The UltraShape proprietary non-invasive body contouring technology is based on focused ultrasound that targets and selectively disrupts fat cells without affecting surrounding structures. Founded in 2000, UltraShape is a privately held and venture backed company with offices in the United States, Israel, France, United Kingdom, and Italy. For more information visit http://www.ultrashape.com.
Gitam Porter Novelli
|SOURCE UltraShape Ltd.|
Copyright©2007 PR Newswire.
All rights reserved